NYSA CTR 1
University of Colorado Health Sciences Center Dr. Elias Balbln_'r Box B-121 4200 Ea._t Ninth Avtnu
Abstract
I am submitting a preliminary application for a research project entitled " Rearrangement mechanisms ingrowing and resting bacteria-A model system for carcinogenesis"
Fields
- Named Organization
- American Cancer Society
- National Institutes of Health (NIH)
- National Science Foundation
- Syracuse University
- *University of California (use specific branch)
- University of Colorado
- University of Michigan
- National Institutes of Health (NIH)
- Named Person
- Bonnet, David M.
- Eisenberg, Arthur D., Ph.D. (CTR Assoc. Research Director 1991, Asst. Secretary 1997)
Defense - Eisenberg, Arthur D., Ph.D. (CTR Assoc. Research Director 1991, Asst. Secretary 1997)
- Date Loaded
- 11 Jan 2006
- Box
- 0001
Document Images
~ University of Colorado Health Sciences Center
Dr. Elias Balbln~'r Box B-121
4200 Ea.~t Ninth Avtnu¢ University Hc~.~pi~ls
..... ~..',.~: (303) 27~5518
School ~f Nursing
Schc~l of D~.ntis~ru"
Fax: (3f.O) 270-5~215
School of P~armzcy
Graduate Sch~:~l
Dr. Arthur Eisenberg
Council for Tobacco Research
900 Third Avenue
New York City, NY 10022
Aug~st~-3 ,'; 1994
Dear Dr. Eisenberg
I am submitting a preliminary application for
a research project entitled " Rearrangement mechanisms ingrowing
and resting bacteria-A model system for carcinogenesis"
The proposed duration of the project is three years and ~the.
projected budget is $ 84,800 per year in direct costs (see page 4).
Thank you very much for your consideration.
Sincerely yours
Elias Balbinder,PhD
Research Professor
Dept. of Biochemistry,
Biophysics and Genetics
Box B 121
Telephone # (303)270-5518
Fax # (303) 270-8215
40000080

1
PROJECT PLA~- ~earrangement meghanisms in growing and resting
bacteria- A model, system for carcinogenesis.
Recent reports that repetitive DNA sequences important in human
genetic disease are highly unstable and mutation prone and that
hereditary colorectal carcinoma cell lines are defective in
mismatch repair (1,2) have shown that predictions based on decades
of reseach with the bacterium E.coli were correct (3"), strength-
ening the relevance of bacterial model systems for studies of
mutations in cancer. It is also clear from recent studies in E.coli
that important differences in mutation mechanisms exist between
actively growing and stationary phase (starvation stressed) cells.
Mutations in actively growing cells are random and generation
dependent while those in stationary phase (non-dividing) cells
seem to be adaptive, i.e. advantageous in direct response to
particular environmental challenges, and are time rather than
generation dependent (4). Stationary phase ~bacteria and actively
growing cells differ completely in their physiology (5), and it is
therefore not surprising that mutations under each of these
conditions occur through different mechanisms with the
participation of distinct sets of genes (4,6). It has been proposed
(7) that cancer cells resemble stationary phase bacteria in that
mutations in them are time dependent and adaptive, thus allowing
them to divide more rapidly than normal cells. We are seeking a
deeper understanding of the different mechanisms involved in the
production of deletions in both actively dividing and starving
E.coli. Our specific objectives are presented below.
I- Deletions in actively growing cells - Involvement of SOS
processing.
Following our demonstration (8) that in actively growing cells
SOS derepression stimulated the deletion of palindromic inserts in
E.coli plasmids we want to test several predictions (below) of our
hypothesis (8) that transient structures which interrupt DNA
replication, such as hairpins formed at palindromic sequences, can
be corrected like mutagenic adducts,i~e, by SOS processing through
a bypass replication mechanism.,
A- If hairpins formed by slippage at palindromic sites are
equivalent to mutagenic lesions they will induce the SOS-response.
This should be easy to determine using strains in which ~ is
under control of SOS promoters (9) so that induction, of SOS
functions, after introducing a plasmid carrying an unstable
palindrome, can be measured byassaying for 5-galactosidase. Such
strains are already in our collection.
B- The stimulation of palindrome deletions in plasmids by SOS
derepression ~equired the presence of excess activated RecA (RecA*
730) and UmuC÷ (8). RecA* may be required for its direct role in SOS
mutagenesis, i.e. facilitation of translesion replication (i0).
since different RecA* alleles stimulated spontaneous mutation to
different extents in an allele specific manner (I0), it is possible
that the same allele-specificity exists for SOS-stimulated
palindrome deletions. If so, we expect that the same RecA'alleles
40000081

in SOS-derepressed (lexA-) strains will stimulate spontaneous point
mutations, mutagen-induced 9oint mutations and palindrome deletions
in plasmids to different extents, but different recA*alleles will
show different spectra of mutation frequencies for each of the
different events. We have a collection of isogenic strains with
different RecA" alleles obtained from Dr. E.Witkin, and some of
these have already been transformed with palindrome-carrying
plasmids. Once all strains are transformed, the measurement of
mutation frequencies is straightforward (see ref.9)
c- Trinh & Sinden (11) presented evidence supporting a
replication-dependent mechanism for deletion of palindromic
sequences using a specially designed set of ~lasmids with
asymmetric palindromic inserts in the catgene of pBR325 in a ~ecA-
strain. We intend to use the same plasmid set to measure deletion
frequencies in strains derepressed for SOS (8). If SOS-stimulation
of palindrome deletion occurs by a bypass replication mechanism
requiring DNA polymerase III, as our model predicts, we will only
see a large increase in deletion frequency when the asymmetric
palindrome is eliminated from the lagging strand of replication, as
Trinh and Sinden have shown (11).
2-A..model for helicase II participation.~n deletion formation in
growing and starving cells.
A- Based on its unique phenotype and map position dli2 is a
mutation in uvrD, the gene for helicase II, and resembles other
null uvrD alleles in stimulating deletion incidence in growing and
non-growing cells (12). It has been suggested that the normal
function for helicase II is to unwind transient deletion
intermediates to restore the pre-slippage configuration (13). Using
a genetic approach we want to test to test a model which proposes
that in growing cells helicase II is part of a replicative pathway
for resolution of deletion intermediates "which requires the SOS
functions RecA and UmuCD,. but in starving cells it is part of a
different pathway which does not require SOS functions.The
experiments will consist of .deletion frequency measurements in
multiple mutant strains carrying different combinations of SOS
alleles (8, 12) with and without dli2, both in growing and non-
growing cells.
B- We have recently isolated a set of suppressors of ~ii2
selected for total loss of Tnl0 excision. These are extremely
interesting and could represent seconday mutations in--giving
a very efficient helicase II, regulatory mutations for genetic
functions under starvation stress control (5), or hovel'alleles for
known components of the DNA metabolism machinery. At this stage
they need to be mapped and characterized genetically.
3- Is rec22~l a_novel allele, of recBC which acts only in starving
cells?.
In plasmid pMC874 (12) deletions of 600-800 bp join the km=
promoter to a promoterless ~ to give a Lac~ phenotype. In the
wild type spontaneous Lac÷deletions start appearing after two days
of incubation on McCo~key's medium, when cells are not actively
2
40000082

growing, and peak at about 4-5 days.Three deletion-associated
events have been identified in plasmid pMC874and there may be mo~e
(12). A mutation selected for increasing Lac~ deletion frequency,
rec2~51, is a ~ allele with a novel phenotype (12). In this
mutant deletion frequenoy is 70-fold higher that in wild type, but
Lac÷ papillae appear within the same time frame as in the wild
type. Reversion of lac- frameshifts requires recA_____/+ and rec~C~ in
starving cells but not in growing cells (6), so it is possible that
the rec2251 RecBC, but not the wild type enzyme, can give rise to
specific deletions in non-dividing cells. We want to determine
whether rec2251-induced deletions can appear as adaptive mutants on
minimal lactose plates over time (i0 days), and whether such
deletions originate from specific events in pMC874. This will be
done by restriction enzyme analysis (12) and sequencing of deletion
end points.
4- Initial character~atiQn .of m~ants which alter the timing
of Tn~0 excision in starving cells. -
I have isolated 35 mutants which alter the timing of Tnl0
excision from three different locations in the ~.coli chromosome:
lac, fuc and ~alK. In some of these mutants~excision occurs early
(one day) and in others much later (4-7 days). Such mutants have
not been isolated before and are extremely interesting since they
may represent mutations in genes which control the overall cell
response to starvation (5) or novel mutations affecting control of
DNA metabolism functions in stationary phase cells, among other
possibilities. I propose to begin their genetic characterization
and mapping. Mutants which turn out to be particularly interesting
will be singled out for intensive study.
REFERENCES
l-T.A.Kunkel (1993) Nature 365:207-208.
2-J.Jiricny (1994) Trends in Genetics 10:164-168.
3-M.Radman and R.Wagner (1993) Nature 36__6:722.
4-P.L.Foster (1993) Ann.Rev.Microbiol. 47:467-504.
5-R.Kolter, D.A.Siegele and A.Tormo (1993)Ann.Rev.Microbiol.47:855-
874.
6-S.M.Rosenberg, S.Longerich, P.Gee-and R.S.Harris (1994). Science
265:405-407; P.L.Foster and J.M.Trimarchi (1994) Science
265:407-409.
7-B.S.Strauss (1992) Cancer Res. 5--2:249-253.
8-E.Balbinder, B.ColI, J.Hutchinson, A.S. Bianchi, T. Groman, K.A.
Wheeler and M. Meyer (1993) Mut. Res. 286: 253-265.
9-C.J. Kenyon and G.C. Walker (1980) PNAS 7_/7: 2819-2823.
10- J.B. Sweasy, E.M. Witkin, N. Sinha, and V. Roegner-Maniscalco
(1990) J.Baot.172~ 3030-3036.
II-T.Q. Trinh and R.R. Sinden .(1991) Nature 252:544-547.
12- E.Balbinder (1993) Mut.Res. 299:193-209
13- S.W. Matson and K.A. Kaiser-Rogers (1990) Ann.Rev. Biochem.
5--9:289-329.
40000063

ESTIMATED DURATION OF DIFFERENT PHASES OF PROJECT
First year: (a) Complete IA and IB (already in progress);(b)
initiate 2 (A and B), 3 and 4.
Second year: (a)Complete IC and 2A;(b) continue 2B ,3 and 4.
Third year: (a) Complete 2A and 3; continue 2B and 4.
ESTIMATED ONE YEAR BUDGET. DIRECT COSTS
A) Personnel
Dr. E.Balbinder (P.I., 50%) .... $40,000 (*)
Technician .................. .. $20,000
• Total salaries ................. $60,000
Fringe benefits (33% sal.) ..... $19,800
Total personnel ................. $79,800
B) Supplies and Miscellaneous
Consummables (culture media,
enzymes, chemicals,glassware,
plasticware, etc) ................ $ 4,000
Miscellaneous (fax, telephone
mail, copies) ...................... $ 1,000
Total supplies and miscellaneous...$ 5,000
Total direct costs ............... $ 84,800
(*) As a Research Professor, E.Balbinder must obtain his salary
from grants.
4
40000084

BIOGRAPHICAL SKETCH
NAME I POSI'I~ TII~
Elias Balbinder I Research Professor
EOUCATtON (Begin m~h baccalaureate or o~her irdtia! lXOfessional edison, ~ as nursing, and lnck.,de
postdocfor~t
[NSTITU'T1ONANOLOCA~ON
Univ. of Michigan, Ann Arbor, R!
Tndiana Univ., Bloomington, ]N
Cargegie Tnst., Cold Spg. Rarb.,
Univ. of Calif., San Diego, CA
DEGREE
Ph.D.
Postdoc
Postdoc
YEAR
CONFERRED
1957
1957-60
1960-63
• FIELD OF STUDY
Zodlog~
Zoology (Genetics
Bacterial Genetics
Biochemistry
RESE.~CH AND PROFESSIONAL EXPERIENCE: Colluding ~ pre~nt position, i=. in ¢ta~mo~gica! orde~ Wevious
emp~oyme~, expeder, ce. and
hono~ Key pemonnel i~lude the principal inve~gator and any other ind~luals ~o padidp~le b the ¢~en~
developme~ ~ exeoj1~ of the WojecL
Key personnel typk:aI~ ~ l~tude ~ ind',Adua~ with doctora~ = other po~=k~'~ai degree, but ~ some
~ojects ~ll Include individu~= = the maste~ ~
baccaJaumate ~vel ~ov~ded they mntnlotde in a substance way to the scientific development or
exeoJPon ~ th~ ~ect. Irtctode ~ese~ membem~p on
any Federal Government puM~ ~ comm~ee. List, in ~m~logical o~de~ the ~les, a8 author& a~ ¢~nptete
m~mnces to ~1 ~¢ations dudng the
past three years and ~ mwesen~e ea~er pu~matio~s ~ ~ ~ ap~icatio~. O0 NOT EXCEEO TWO PAGES.
1963-67 Assistant Professor of Genetics, Dept. of Bacteriology and Botany, Syracuse
University, Syracuse, NY.
1967-71 Associate Professor of Genetics, Dept. of Bacteriology and Botany, Syracuse
University, Syracuse, HY.
1971-76 Professor of Genetics, Dept. of Biology, Syracuse University, Syracuse, NY.
1976-82 Head, Laboratory of Genetics and Carcinogensis, AHC Cancer Research Cente~
and Hospital, Lakewood, Colorado.
1982-93 Ad3unct Professor, Dept. of Biochem/Biophys/Genetics, University of
Colorado Health Sciences Center, Denver, Colorado
1993- Research Professor, Dept. of Biochem/Biophys/Genetics, University of
Colorado Hea]Eh Sciences Center, Denver, Colorado
Fellowships, etc.
1960-63
Zl6S-SlSS
z/70-8/70
]977-79
6/ez-9/eI
Postdoctoral Research Fellow, American Cancer Society - Laboratory of Dr.
David M. Bonnet, University of California, LaOolla, California.
Fulbright-Hays Award to conduct research at the Department of Biology~
Univ.of Buenos Aires, Argentina.
Special Fellowship of the NaEional Institute of Health. To conduct research
in the laboratory of Dr. Aizo Matsushiro, Osaka University, Osaka, ~apan.
Member, National Science Foundation Panel on Genetic Biology.
Recipient of Fulbright-Hays Award and Visiting Professor, Univ. of Los
Andes, Bogota, Colombia. To teach course in Molecular Genetics.
publications..duEin9 the past three yeaKs
Balbinder, E. and Waldren, C. A review of DHA metabolism in E, coll.
Cell Biology Reviews ~5:105-155 (199i).
Balbinder, E.,Co11,B.,Hutchinson,O.,Bianchi,A.S. and Groman,T., Wheeler,K.A. and
Meyer,M. Participation of the SOS system in producing deletions in ~
plasmids. Mutn. Res. 286:253-265 (1993).
Balbinder,E. Multiple pathways for deletions in Esch~ichia coli. Mut. Res.
299:193-209(1993).
Levy,M.$., Balbinder,E.and Nagel,R. Effect of mutations in SOS genes on UV-
induced precise excision of TnlO in Escherichia coli. Mut. Res.293:241-~#7 (1993).
PHS 338 (Rev. &~l) (Fc~rm Pa;e 6) Page
FF
40000085

Principal
ReDresentative ~ertinent earlier oublications
1. Callahan,R.and Balbinder,E. Tryptophan operon: Structural gene cutatton creating a
"promoter" and leading to 5-methyltryptophan dependence. Science ]68:]586-1589
(lg70).
2. LaScolea, L.J., and BalbindeP, E. Restoration of phosphoribosyltransferase
activity by partially deleting the ~ gene of the tryptophan operon of
~.tvDhi~uriu~. J. Bact. 112:877-885 (1972).
3. Mocrina,F.L. and 8albinder, E. Plasmid associated functions of a stable F'lac.
Bact. 113:1183-1191 (1973).
4. Mocrina, F.L., Balbinder, E., and Bassel, Alix, Molecular characterization of a
stable F']acplasmid. Bioche~. & Biophys. Res. Com. 54:737-743 (1973).
5. Callahan,. R. III, Dooley,H.H., and Balbinder, E. A mutation to 5-methyltryptophan
dependence in the tryptophan (trp) operon of Salmonella tvDhimuriU~. II. Studies
of 5-methyltryptophan-dependent mutants and their revertants. Mo]ec. Gen. Genet.
]65:129-143 (1978).
6. LaScolea, L.J., Oooley, H.H., lorget, R., and Balbtnder, E. A mutation to
5-~ethyltryptophan dependence in the rt~Jl operon of Salmonella
Correlation between phenotype and the wope~ties of the second enz)Ine fop
tryptophan biosynthesis in a 5-methyltryptophan dependent mutant and several
5-methyltryptophan-independent revertants. Molec; ~en. Genet. 165: 145-153
(1978).
7. Angelosanto, F.A., ~orget,R., and Balbtnder, E. A ~utation to a
5-~ethyltryptophan dependence in the ~ operon of Salmonell~ tTphi~uriu~. IV.
Isolation and characterization of tJ:llpro~oter mutations. Molec. Gen. Genet. 165:
8. Dooley, M. and Balbinder, E. Differences between the Anthranilate-5-phosphoribosy]
pyrophospate phosphoribosyltransferases of Salmonell~ typhimurium strains LT2 and
LT7. J.Gen. ~icrobiol. 112:171-179 (1979).
9. Balbinder, E., Reich, C.I., Shugarts, D., Keogh, ~., Fibiger, R., Jones, i., and
Banks, A. Relative mutagentcity of some urinary~etabolites of the antitu~or drug
cyclophosphamide. Cancer Research 41:2967-2972 (1981).
10. Balbtnder, E., Kerw, D. and Reich, C.I. Deletton induction in bacteria. ~. ihe
Pole of mutagens and cellular error-prone repair. Hut.Reg. 112:147-168 (1983).
11. Balbinder, E., Stick, $.H. and Sharma, O.K. Complex effects of retinol on the
metabolic activation of 2-a~inofluorene. Env. Hut. ~: 665-678 (1983)
12. Balbinder, E. and Kerry O. A ne~ strain of Salmonella ty~hvmurtU~ reverted by
mitomycin C and N-methyl-N-nitro-N-nitrosoguanidine; a possible universal tester
for Inutagentc compounds. Hut. Reg. 130:315-320 (198~).
13. Balbtnder, E. Use of pre-designed plasmtds to study deletions: strategies for
dealing with a complex problem.Chapter 40, pp.378-391-ASM, Washington, D.C. In~_N~
Replication and Motaoenesl$. Eds.R.E.Moses and W.C.Su~ners (1988).
14, Balbinder,E.,HacVean,C. and ~illiams,R.E. Overlaping direct re,eats stimulate
deletions on specially designed derivatives of plasmid pBR325 ]n cF.~_~jL. ~ut.Res.
214:233-252 (1989).
Page 31
40000086

CURRENTLY ACTIVE GRANTS, CONTRACTS and OTHER SOURCES of FUNDS
List financial support .([direct costs, only) from all sources, inctudin~ own institution.
Title of Projec~
Regulation of synthesis se-
cretion of salivary proteins.
(co-PI; K.N.Prasad,PI]
Construction of E.coli strait
useful for stabilizing un-
clonable DNA sequences (con-
tract)
Sources
(give grant
numbers)
NIH- ROI
9EO9589
s Life
Inc.
Gaithersbu
Total Value
of C~ant
(d~t
1,278,155
(5 ys.)
$12,000
:g
Cun-ent
Annual Amount
A~ilable
to You
$ 18,000
(22% salaryl
$12,000
Date of
Termination
of Grant
9-30-94
(my part.
9-30-94
Identify and describe any overlap oft~s applic~ion with the above grants:
No overlap- There has been no funding for the project in this application
since 1992.
Indicate the total annual funds available to you this year for all research
projects under your supervision.
12,000
PENDING 0K PLANNED
Title of Project
Construction of E.coli
strains .... (see above)
(contract) (pending)
Sources
n,umb.ers)
Life Tech.
InOo
Total Value
of Grant
(direct costs)
$ 50,000
Avg. A~mual
Amount
Available to You
50,000
Total Duration
(give inclusive
dates)
1 year
(10-1-94 thro
9-30-95)
Identify and describe any overlap &this application with the above project.
He overlap-
Application to NSF and NIH of a prposal to study X-ray-induced deletions
planned for some time this year depending on completion of preliminary
experiments.
tgh
40000087
